RESULTS	The difference in the change in the UPDRS Part III ( ON state ) sum score from baseline to the end of treatment between rotigotine and placebo groups was-6 .41.2 ( 95 % CI : -8.7 to-4 .1 ; p < 0.001 ) , indicating superiority of rotigotine over placebo .\